CHI3L1 and melanoma: The levels of circulating CHI3L1 are also increased in cancers of the prostate, colon, lung, rectum, ovary, kidney, breast, glioblastomas and malignant melanoma where they frequently correlate with disease progression and inversely with disease-free interval and survival (19–27).